Key features and details
- Rabbit polyclonal to MAP3K1 (phospho T1400)
- Suitable for: WB
- Reacts with: Human
- Isotype: IgG
Product nameAnti-MAP3K1 (phospho T1400) antibody
See all MAP3K1 primary antibodies
DescriptionRabbit polyclonal to MAP3K1 (phospho T1400)
ab138662 detects endogenous levels of MAP3K1 only when phosphorylated at T1400 in Human samples or at T1381 in Mouse samples.
Tested applicationsSuitable for: WBmore details
Species reactivityReacts with: Human
Predicted to work with: Rat
Synthetic peptide corresponding to Human MAP3K1 (internal sequence). Immunogen derived a synthesized phospho-peptide from human MAP3K1 around the phosphorylation site of Thr1400.
Database link: Q13233
This product was previously labelled as MEKK1
Reproducibility is key to advancing scientific discovery and accelerating scientists’ next breakthrough.
Abcam is leading the way with our range of recombinant antibodies, knockout-validated antibodies and knockout cell lines, all of which support improved reproducibility.
We are also planning to innovate the way in which we present recommended applications and species on our product datasheets, so that only applications & species that have been tested in our own labs, our suppliers or by selected trusted collaborators are covered by our Abpromise™ guarantee.
In preparation for this, we have started to update the applications & species that this product is Abpromise guaranteed for.
We are also updating the applications & species that this product has been “predicted to work with,” however this information is not covered by our Abpromise guarantee.
Applications & species from publications and Abreviews that have not been tested in our own labs or in those of our suppliers are not covered by the Abpromise guarantee.
Please check that this product meets your needs before purchasing. If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, as well as customer reviews and Q&As.
Storage instructionsShipped at 4°C. Store at -20°C.
Storage bufferpH: 7.40
Preservative: 0.02% Sodium azide
Constituents: 49% PBS, 50% Glycerol, 0.88% Sodium chloride
PBS is without Mg2+ and Ca2+
Concentration information loading...
PurityImmunogen affinity purified
Purification notesab138662 was purified from Rabbit antiserum. The antibody against non phosphopeptide was removed by chromatography using non phosphopeptide corresponding to the phosphorylation.
Our Abpromise guarantee covers the use of ab138662 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/500 - 1/1000. Predicted molecular weight: 164 kDa.|
FunctionComponent of a protein kinase signal transduction cascade. Activates the ERK and JNK kinase pathways by phosphorylation of MAP2K1 and MAP2K4. Activates CHUK and IKBKB, the central protein kinases of the NF-kappa-B pathway.
Sequence similaritiesBelongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase kinase subfamily.
Contains 1 protein kinase domain.
Contains 1 RING-type zinc finger.
Contains 1 SWIM-type zinc finger.
- Information by UniProt
- M3K1_HUMAN antibody
- MAP3K1 antibody
- MAPK/ERK kinase kinase 1 antibody
Anti-MAP3K1 (phospho T1400) antibody (ab138662) at 1/500 dilution + extracts from Jurkat cells at 30 µg
Predicted band size: 164 kDa
All lanes : Anti-MAP3K1 (phospho T1400) antibody (ab138662) at 1/250 dilution
Lane 1 : Mouse B16F10 whole cell lysate - untreated
Lane 2 : Mouse B16F10 whole cell lysate - treated with 5µM Osteoponin for 10 minutes
Lysates/proteins at 60 µg per lane.
All lanes : HRP-conjugated goat anti-rabbit IgG polyclonal at 1/10000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 164 kDa
Observed band size: 150 kDa why is the actual band size different from the predicted?
Exposure time: 2 minutes
ab138662 has been referenced in 2 publications.